Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) by event type

KNSA moves most on coverage initiations — a median of -0.77% at 30 minutes across 16 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the KNSA overview →

By event type

How KNSA reacts across 4 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst downgrades
1,647 of 2,603
11-0.09%46%+0.69%
Coverage initiations
2,043 of 2,283
16-0.77%31%+1.93%
Rating reiterations
1,137 of 3,522
42+0.06%52%-0.65%
Price-target raises
1,538 of 1,790
30-0.18%47%-0.28%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.

That’s how KNSA usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · KNSA overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
LeMaitre Vascular, Inc. (LMAT)430+0.05%54%
TRULIEVE CANNABIS CORP (TCNNF)429+0.41%58%
Veracyte, Inc. (VCYT)427-0.15%46%
Moleculin Biotech, Inc. (MBRX)426-0.21%43%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.